Evidence map›Paper›PMID 40150686›Full record

ArticleBioengineering (Basel, Switzerland)2025

A Deep Convolution Method for Hypertension Detection from Ballistocardiogram Signals with Heat-Map-Guided Data Augmentation.

Renjie Cheng, Yi Huang, Wei Hu, Ken Chen, Yaoqin Xie

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Renjie ChengShenzhen HUAYI Medical Technologies Co., Ltd., Shenzhen 518055, China.
Yi HuangShenzhen HUAYI Medical Technologies Co., Ltd., Shenzhen 518055, China.ORCID 0000-0002-6915-1208
Wei HuShenzhen HUAYI Medical Technologies Co., Ltd., Shenzhen 518055, China.
Ken ChenShenzhen lnstitute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.ORCID 0000-0002-4519-9362
Yaoqin XieShenzhen lnstitute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.ORCID 0000-0002-1412-2354

Funding

National Key Research and Develop Program of China 2022YFC2409000National Natural Science Foundation of China U20A20373Shenzhen Science and Technology Program KQTD20180411185028798
6 · The paper itself

Abstract

Hypertension (HPT) is a chronic disease characterized by the consistent elevation of arterial blood pressure, which is considered to be a significant risk factor for conditions such as stroke, coronary artery disease, and heart failure. The detection and continuous monitoring of HPT can be a demanding process. As a non-contact measuring method, the ballistocardiography (BCG) signal characterizes the repetitive body motion resulting from the forceful ejection of blood into the major blood vessels during each heartbeat. Therefore, it can be applied for HPT detection. HPT detection with BCG signals remains a challenging task. In this study, we propose an end-to-end deep convolutional model BH-Net for HPT detection through BCG signals. We also propose a data augmentation scheme by selecting the J-peak neighborhoods from the BCG time sequences for hypertension detection. Rigorously evaluated via a public data-set, we report an average accuracy of 97.93% and an average F1-score of 97.62%, outperforming the comparative state-of-the-art methods. We also report that the performance of the traditional machine learning methods and the comparative deep learning models was improved with the proposed data augmentation scheme.

Indexed as

ballistocardiography signaldeep learninghypertension detection

Identifiers

PMID40150686
PMCPMC11939193

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.